Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116)

Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2532
Sku # A2532-1mg*25
Pricing 1mg*25, $2970.00
Feedback